# BioTime

BioTime is an Asset Manager based in Karlsruhe, Germany.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Karlsruhe, Germany
- **Region:** Europe
- **Address:** Karlsruhe, Germany
- **Assets under management:** Undisclosed
- **LinkedIn:** https://www.linkedin.com/company/biotime

## Regulatory record

- **Reports private funds:** No

## About

BioTime's founding year is not publicly documented. The firm lists offices in Karlsruhe, Germany, Alameda, California, and Amsterdam, Netherlands, but names no principals or investment team members on any accessible platform. Strategy and deployment data are absent from public sources. No known fund structures, stage preferences, or portfolio companies have been disclosed. The geographic footprint spans Western Europe and the U.S. West Coast, potentially indicating a transatlantic healthcare or life-sciences investment focus, but no deal evidence supports this. Scale and team size are unknown. No professionals count, AUM, or recent operational events have been reported. No philanthropic vehicles or adjacent structures have been identified. The firm's structural differentiator is its lack of public footprint — an opaque multi-city operation with no verifiable investment history. This may reflect an intentional low-profile posture or a newly established entity without public track record.

## Sectors

- Healthcare Services
- Life Sciences

## Offices

- Alameda, United States
- Amsterdam, Netherlands

## Questions

### Who runs investment decisions at BioTime?

BioTime has not publicly named any investment decision-makers or team members. No leadership information is available from any source.

### How does BioTime source proprietary deal flow?

There is no public information on BioTime's sourcing strategy. The firm does not disclose any deal origination methods or partnerships.

### Does BioTime participate in fund commitments or only direct deals?

No information is available about BioTime's investment approach—whether it makes fund commitments, direct investments, or uses other structures.

### What investment stages does BioTime typically target?

BioTime has not disclosed any stage preference or investment focus. No known deals or portfolio companies are on record.

### Which sectors does BioTime explicitly avoid?

BioTime has not publicly communicated any sector exclusions. Its focus is unknown.

## Related profiles

- [Genesis Energy](https://altss.com/profile/genesis-energy)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/biotime

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology